ES2122767T3 - Composiciones farmaceuticas que comprenden derivados de dinoreburnamenina. - Google Patents

Composiciones farmaceuticas que comprenden derivados de dinoreburnamenina.

Info

Publication number
ES2122767T3
ES2122767T3 ES96400419T ES96400419T ES2122767T3 ES 2122767 T3 ES2122767 T3 ES 2122767T3 ES 96400419 T ES96400419 T ES 96400419T ES 96400419 T ES96400419 T ES 96400419T ES 2122767 T3 ES2122767 T3 ES 2122767T3
Authority
ES
Spain
Prior art keywords
dinoreburnamenine
pharmaceutical compositions
compositions including
including derivatives
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96400419T
Other languages
English (en)
Inventor
Philippe Becourt
Jean-Luc Dubois
Pierre Metziger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel, Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel
Application granted granted Critical
Publication of ES2122767T3 publication Critical patent/ES2122767T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

LA INVENCION SE REFIERE A LAS CAPSULAS BLANDAS CONSTITUIDAS POR UNA ENVOLTURA DE CAPSULA Y POR UNA MEZCLA DE RELLENO DE CAPSULA, CARACTERIZADAS POR QUE: A) LA ENVOLTURA DE CAPSULA CONTIENE GELATINA Y EVENTUALMENTE UN PLASTIFICANTE Y OTROS ADITIVOS, B) LA MEZCLA DE RELLENO DE CAPSULA CONTIENE UN COMPUESTO DE FORMULA (I) O UNA SAL DE ADICION DE DICHO COMPUESTO DE FORMULA (I) EN LA QUE R{SUB,1}, R{SUB,2 Y R{SUB,3}, IDENTICOS O DIFERENTES, REPRESENTAN POR EJEMPLO UN ATOMO DE HIDROGENO O UN RADICAL ALQUILO, Y C) LA MEZCLA DE RELLENO DE CAPSULA COMPRENDE TAMBIEN UNA O VARIAS MATERIAS DE GRUPO FORMADO POR LOS ACEITES MINERALES.
ES96400419T 1995-03-03 1996-02-28 Composiciones farmaceuticas que comprenden derivados de dinoreburnamenina. Expired - Lifetime ES2122767T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9502482A FR2731154B1 (fr) 1995-03-03 1995-03-03 Compositions pharmaceutiques comprenant des derives de dinoreburnamenine

Publications (1)

Publication Number Publication Date
ES2122767T3 true ES2122767T3 (es) 1998-12-16

Family

ID=9476702

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96400419T Expired - Lifetime ES2122767T3 (es) 1995-03-03 1996-02-28 Composiciones farmaceuticas que comprenden derivados de dinoreburnamenina.

Country Status (9)

Country Link
US (1) US5707651A (es)
EP (1) EP0729749B1 (es)
JP (1) JPH08325148A (es)
AT (1) ATE171618T1 (es)
CA (1) CA2170844A1 (es)
DE (1) DE69600702T2 (es)
DK (1) DK0729749T3 (es)
ES (1) ES2122767T3 (es)
FR (1) FR2731154B1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869500A (en) * 1996-12-13 1999-02-09 Hoffmann-La Roche Inc. Pyridone compounds useful in treating Alzheimer's disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2381048A1 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives de 20,21-dinoreburnamenine, un procede pour leur preparation et leur application comme medicaments
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
FR2623501B1 (fr) * 1987-11-19 1990-03-16 Roussel Uclaf Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant
IT8922398A0 (it) * 1989-11-16 1989-11-16 Phidea Spa Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva.
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5178877A (en) * 1991-01-04 1993-01-12 Abbott Laboratories Encapsulated renin inhibitor composition

Also Published As

Publication number Publication date
FR2731154A1 (fr) 1996-09-06
EP0729749A1 (fr) 1996-09-04
DK0729749T3 (da) 1999-06-21
US5707651A (en) 1998-01-13
DE69600702T2 (de) 1999-04-01
ATE171618T1 (de) 1998-10-15
EP0729749B1 (fr) 1998-09-30
DE69600702D1 (de) 1998-11-05
JPH08325148A (ja) 1996-12-10
FR2731154B1 (fr) 1997-05-09
CA2170844A1 (fr) 1996-09-04

Similar Documents

Publication Publication Date Title
ES2082805T3 (es) Derivados de tiazol, procedimientos para su produccion y composiciones farmaceuticas que comprenden los mismos.
FI972062A0 (fi) Substituoituja 4-biaryylivoi- tai 5-biaryylipentaanihappoja ja johdannaisia matriisimetalliproteaasi-inhibiittoreina
ES2084808T3 (es) Uso de un fosfato de un alfa-tocoferol, o de uno de sus derivados para la preparacion de composiciones cosmeticas, dermatologicas, o farmaceuticas; composiciones asi obtenidas.
GR861118B (en) 7-substituted bicyclic pyrazolidinones
DE69221721D1 (de) Ethanolaminderivate mit anti-pollakiurawirkung
KR900003163A (ko) 시클로헥산 유도체
HUT49349A (en) Process for producing substituted 6-phenyldihydro-3-/2h/-pyridazinone derivatives and pharmaceutical compositions comprising such compounds
HUT40126A (en) Process for producing 6,7-disubstituted-1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphtiridine-3-carboxylic acid derivatives and pharmaceutical compositions and food additives containing them
ES2122767T3 (es) Composiciones farmaceuticas que comprenden derivados de dinoreburnamenina.
ES2058177T3 (es) Nuevos derivados de alcanosulfonanilida, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
FI941836A0 (fi) 3-deoksioligosakkaridit, menetelmiä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FR2663328B1 (fr) Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
DE3868013D1 (de) Thiazolderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
IL85822A (en) 7-alkanesulphonoamido-1,2,4,5-tetrahydro-3h-3-benzazepine derivatives,their preparation and pharmaceutical compositions containing them
ES2057802T3 (es) Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen.
BR9203643A (pt) Derivados de 3-cicloalquil-propen-2-amida e processo para sua preparacao,medicamentos e composicoes farmaceuticas
FR2666809B1 (fr) Systeme anti-oxydant a base d'un acide amine basique en association avec au moins un tocopherol ou et de ses derives et au moins un polypeptide non thiole et compositions contenant un tel systeme anti-oxydant.
DK168284A (da) Troponderivater
EE9800134A (et) Farmatseutiline kompositsioon intravenoosseks manustamiseks
PT92377A (pt) Processo para a obtencao de composicoes farmaceuticas para o tratamento de estados depressivos, contendo derivados de cromano
PT979816E (pt) Novos derivados de acido hidroxamico, processo para a sua preparacao e as composicoes farmaceuticas que os contem
IL119054A (en) Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them
PT95600A (pt) Processo para a preparacao de novos derivados substituidos na posicao 15 da 20,21-dinoreburnamenina e de composicoes farmaceuticas que os contem
KR850003711A (ko) 진통 작용을 지닌 피롤-3-카르복실산의 제조방법

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 729749

Country of ref document: ES